Parameters | OS | PFS | LRRFS | DMFS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P |
STC2 | 7.534 | 0.928-61.197 | 0.059 | 7.853 | 1.825-33.796 | 0.006* | 2.080 | 0.347-12.484 | 0.423 | 8.065 | 1.056-61.572 | 0.044* |
T classification | 0.610 | 0.105-3.534 | 0.582 | 0.590 | 0.180-1.932 | 0.383 | 0.176 | 0.032-0.954 | 0.044* | 0.816 | 0.179-3.729 | 0.794 |
N classification | 3.723 | 0.852-16.270 | 0.081 | 2.316 | 1.023-5.244 | 0.044* | 1.229 | 0.224-6.754 | 0.812 | 4.105 | 1.168-14.431 | 0.028* |
Clinical stages | 6.517 | 2.015-21.082 | 0.002* | 1.667 | 0.807-3.442 | 0.167 | 1.161 | 0.337-4.003 | 0.813 | 2.596 | 1.066-6.323 | 0.036* |
RT vs CRT | 0.278 | 0.051-1.507 | 0.138 | 0.906 | 0.268-3.067 | 0.874 | 3.561 | 0.286-44.327 | 0.324 | 0.364 | 0.081-1.632 | 0.187 |
IMRT vs 2D-RT | 0.351 | 0.077-1.597 | 0.176 | 1.085 | 0.422-2.792 | 0.865 | 0.122 | 0.027-0.557 | 0.007* | 5.917 | 1.548-22.610 | 0.009* |
Residual tumor | 0.876 | 0.229-3.354 | 0.846 | 0.249 | 0.084-0.740 | 0.012* | 0.771 | 0.153-3.895 | 0.753 | 0.113 | 0.025-0.505 | 0.004* |